Table 2.
Study group | Control group | |
---|---|---|
Processing time (d)a | ||
Minimum | 0 | 1 |
Maximum | 7 | 23 |
Mean ± SD | 0.8 ± 1.1 | 6.6 ± 3.6 |
Median | 1.0 | 6.0 |
Antibiotic treatment prehospitallyb | 46 (16.3) | 57 (12.3) |
Antibiotic treatmentb | ||
Overall collective | 145 (45.0) | 197 (42.5) |
Age > 12 mo | 76 (42.7) | 124 (45.6) |
EnterVir/hRV | 46 (44.7) | 57 (37.3) |
RSV | 32 (48.5) | 48 (41.0) |
AdenVir | 16 (61.5) | 6 (75.0) |
hMPV | 6 (35.3) | 4 (50.0) |
Antiviral treatmentb | ||
Oseltamivir | 6 (1.9) | 4 (0.9) |
Oseltamivir + antibiotics | 3 (2.1) | 1 (0.5) |
Oseltamivir ‐ antibiotics | 3 (1.7) | 3 (1.1) |
Duration of antibiotic therapy (d)a | ||
Overall collective | ||
Minimum | 1.0 | 1.0 |
Maximum | 39.0 | 49.0 |
Mean ± SD | 9.1 ± 5.4 | 8.6 ± 4.4 |
Median | 9.0 | 7.0 |
25%‐percentile | 7.0 | 7.0 |
75%‐percentile | 10.0 | 10.0 |
Age > 12 mo | ||
Minimum | 1.0 | 1.0 |
Maximum | 39.0 | 49.0 |
Mean ± SD | 9.7 ± 5.4 | 9.0 ± 4.6 |
Median | 10.0 | 8.0 |
25%‐percentile | 7.0 | 7.0 |
75%‐percentile | 11.0 | 10.0 |
Length of hospital stay (d)a | ||
Overall collective | ||
Minimum | 1.0 | 0,0 |
Maximum | 65.0 | 51.0 |
Mean ± SD | 4.7 ± 5.4 | 4.7 ± 4.4 |
Median | 3.0 | 4.0 |
25%‐percentile | 2.0 | 2.0 |
75%‐percentile | 6.0 | 6.0 |
Age > 12 mo | ||
Minimum | 1.0 | 0 |
Maximum | 65.0 | 44.0 |
Mean ± SD | 4.4 ± 5.6 | 4.3 ± 4.1 |
Median | 3.0 | 3.0 |
25%‐percentile | 2.0 | 2.0 |
75%‐percentile | 4.0 | 5.0 |
EnterVir/hRV | 3.0 | |
Minimum | 1.0 | 0.0 |
Maximum | 65.0 | 44.0 |
Mean ± SD | 4.8 ± 6.8 | 4.3 ± 4.4 |
Median | 3.0 | 3.0 |
RSV | ||
Minimum | 1.0 | 1.0 |
Maximum | 56.0 | 17.0 |
Mean ± SD | 6.3 ± 6.8 | 5.1 ± 2.7 |
Median | 5.0 | 5.0 |
AdenVir | ||
Minimum | 2.0 | 2.0 |
Maximum | 9.0 | 6.0 |
Mean ± SD | 3.9 ± 1.9 | 4.0 ± 1.3 |
Median | 3.0 | 4.0 |
hMPV | ||
Minimum | 2.0 | 2.0 |
Maximum | 23.0 | 19.0 |
Mean ± SD | 5.0 ± 4.8 | 6.0 ± 5.5 |
Median | 4.0 | 4.0 |
Continuous variables: median, minimum, maximum, mean ± standard deviation (SD).
Binary variables: absolute and relative number.